1.4% SEP Increase Impacts Pharmaceutical Investment

Original Article by Linda Ensor | Business Day | 7 December 2025

Understanding the 1.4% SEP increase: why the pharmaceutical sector is urging a reconsideration of the price cap.

Understanding the 1.4% SEP increase: why the pharmaceutical sector is urging a reconsideration of the price cap.

Subscription Required

You must be a subscriber to access all of this content.

View Subscriptions

Already a subscriber? Log in here